On this week’s Prognosis Ohio, Dan Skinner talks with reporter Marty Schladen from the Ohio Capital Journal about Pharmacy Benefit Manager’s (PBM) and the “obscure scheme” that has Ohio taxpayers paying much more than they should for Medicaid drugs. In the episode, Skinner and Schladen discuss how this issue has developed since 2018 and offer thoughts on pending legal action in this year and the next. For many, these issues with pharmaceutical middlemen are signs of trouble – both for Ohioans’ health care needs and the fiscal sustainability of Ohio’s Medicaid program – unless how the state approaches PBMs can be radically reformed.
- As the Coronavirus Spreads, Drug Pricing Legislation Remains Stalled
- Companies have raised prices on 245 drugs during pandemic, advocacy group says